tci Medicare Compliance & Reimbursement - 2021 Issue Q2

AMA Offers Imminent Novavax Vaccine Code Update

On May 4, the American Medical Association (AMA) announced provisional CPT® codes for the yet-to-be approved COVID-19 vaccination from Novavax Inc. The AMA decided to release codes before the Food and Drug Administration (FDA) Emergency Use Authorization (EUA) approval of the Novavax COVID-19 Vaccine “to ensure electronic systems across the U.S. health care system are prepared in advance,” explains an AMA release on the update. Here’s a breakdown of the CPT® codes for the Novavax vaccine and vaccine administration: 91304 (Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.